Sequent Scientific Limited Stock

Equities

SEQUENT

INE807F01027

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:47 2024-04-23 am EDT 5-day change 1st Jan Change
122.4 INR -0.85% Intraday chart for Sequent Scientific Limited -0.85% +7.51%
Sales 2022 14.13B 170M Sales 2023 14.21B 171M Capitalization 18.04B 217M
Net income 2022 413M 4.96M Net income 2023 -1.21B -14.56M EV / Sales 2022 2.55 x
Net Debt 2022 3.06B 36.75M Net Debt 2023 4.02B 48.28M EV / Sales 2023 1.55 x
P/E ratio 2022
81.1 x
P/E ratio 2023
-14.9 x
Employees 1,301
Yield 2022 *
-
Yield 2023
-
Free-Float 45.8%
More Fundamentals * Assessed data
Dynamic Chart
Sequent Scientific's Joint Managing Director Resigns MT
Sequent Scientific Limited Announces Resignation of Sharat Pandurang Narasapur, Jt. Managing Director, from the Board of Directors, Member of the Corporate Social Responsibility Committee of the Board Effective on April 30, 2024 CI
Transcript : Sequent Scientific Limited, Q3 2024 Earnings Call, Feb 15, 2024
Sequent Scientific Limited Announces Executive Changes CI
Sequent Scientific Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Sequent Scientific Limited Announces Resignation of Krunal Shah as Company Secretary & Compliance Officer, Effective on February 15, 2024 CI
Sequent Scientific Appoints CFO MT
Transcript : Sequent Scientific Limited, Q2 2024 Earnings Call, Nov 07, 2023
Sequent Scientific's CFO Resigns MT
Sequent Scientific Limited Announces Patri Venkat Raghavendra Rao as Chief Financial Officer CI
Transcript : Sequent Scientific Limited, Q1 2024 Earnings Call, Aug 11, 2023
Sequent Scientific Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Sequent Scientific Discontinues Manufacturing Operations at Tarapur Unit in India MT
Sequent Scientific Limited Announces Discontinuation of Manufacturing Operations At Tarapur, Maharashtra CI
Transcript : Sequent Scientific Limited, Q4 2023 Earnings Call, May 24, 2023
More news
1 day-0.85%
1 week-0.85%
Current month+6.16%
1 month+5.34%
3 months-10.69%
6 months+17.12%
Current year+7.51%
More quotes
1 week
116.45
Extreme 116.45
124.80
1 month
112.40
Extreme 112.4
134.95
Current year
112.00
Extreme 112
155.45
1 year
70.15
Extreme 70.15
155.45
3 years
61.80
Extreme 61.8
336.40
5 years
52.00
Extreme 52
336.40
10 years
42.45
Extreme 42.45
336.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 22-04-10
Director of Finance/CFO - Nov. 05
Chief Administrative Officer - 13-12-31
Members of the board TitleAgeSince
Director/Board Member 55 20-08-16
Chairman 76 20-08-24
Director/Board Member 64 20-08-24
More insiders
Date Price Change Volume
24-04-23 122.4 -0.85% 104,055
24-04-22 123.4 +3.52% 50,798
24-04-19 119.2 -0.13% 121,282
24-04-18 119.4 -2.53% 62,817
24-04-16 122.5 -0.77% 39,816

Delayed Quote Bombay S.E., April 23, 2024 at 06:00 am EDT

More quotes
SeQuent Scientific Limited is an India-based animal health company. The Company provides a wide range of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), as well as analytical services. The Company operates through the pharmaceuticals segment. The Company is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It is specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It provides analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer developed methods or in-house method development. Its subsidiaries include Alivira Animal Health Limited and SeQuent Research Limited.
Calendar
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. SEQUENT Stock